Key result
Acute propranolol fails to alter heart rate recovery kinetics compared to placebo in healthy men.
Why the study?
Estimating exercise heart rate from postexercise pulse count may be invalid if beta-adrenergic blockade shortens heart rate recovery kinetics after exercise.
Does acute propranolol administration alter heart rate recovery kinetics after submaximal exercise in healthy men?
RCT (n=9)
Double-blind
Random order
Does acute propranolol administration alter heart rate recovery kinetics after submaximal exercise in healthy men?
p-value: p=>0.05
Acute beta-blockade does not alter heart rate recovery kinetics, validating the use of 15-second postexercise pulse counts to estimate exercise heart rate in patients on beta-blockers.
Acute propranolol leaves heart rate recovery kinetics unchanged; supports 15-second postexercise pulse counts for intensity estimation in beta-blocked patients.
In patients treated with beta-adrenergic blocking agents, the practice of estimating exercise heart rate (HR) from postexercise pulse count may be invalid if beta-adrenergic blockade (BB) shortens the time course of heart rate recovery (heart rate recovery kinetics or HRK) after acute exposure to exercise. To determine the effect of nonspecific BB on HRK in nine healthy, drug-free men, HR was calculated from ECG recordings during submaximal (70. % HR max reserve) cycle ergometer exercise and every 4 seconds for 2 minutes of recovery under both BB (80 mg propranolol) and placebo (PL) treatments (random order, double-blind); half-times of the HR recovery curves were subsequently calculated. Data analysis (2 ± 31 randomized block factorial ANOVA; critical P < 0.05) revealed that: (1) HR was significantly reduced by BB, (2) HR decreased significantly by the twelfth second of recovery, and (3) the treatment-by-time interaction term was not significant suggesting parallelism of the BB and PL HR recovery curves. Polynomial regression demonstrated that a second-order function provided optimal fit of the HRK data under both treatment conditions. In addition, HR recovery curve half-times were similar between treatments (ANOVA, P > 0.05). Finally, HRs calculated from the last 15 seconds of exercise and the first 15 seconds of recovery were not significantly different; ingestion of BB did not affect this finding, although exercise and recovery HRs were reduced by BB treatment. These results demonstrate that HRK is unaffected by acute ingestion of nonspecific BB, and, if the pulse count is completed within the first 15 seconds after exercise cessation, estimating exercise HRs from postexercise pulse counts remains a valid procedure for patients receiving BB.
No takes yet. Share an insight, caveat, or question.
Crouse et al. (1989) conducted an RCT in Healthy (n=9). Propranolol vs. Placebo was evaluated on Heart rate recovery curve half-times (p=>0.05). Acute ingestion of 80 mg propranolol did not significantly affect heart rate recovery curve half-times compared to placebo in healthy men (P>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: